These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

593 related items for PubMed ID: 33670231

  • 1. Distribution of Human Papillomavirus (HPV) Genotypes in HIV-Negative and HIV-Positive Women with Cervical Intraepithelial Lesions in the Eastern Cape Province, South Africa.
    Taku O, Mbulawa ZZA, Phohlo K, Garcia-Jardon M, Businge CB, Williamson AL.
    Viruses; 2021 Feb 11; 13(2):. PubMed ID: 33670231
    [Abstract] [Full Text] [Related]

  • 2. Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain.
    Perez S, Iñarrea A, Pérez-Tanoira R, Gil M, López-Díez E, Valenzuela O, Porto M, Alberte-Lista L, Peteiro-Cancelo MA, Treinta A, Carballo R, Reboredo MC, Alvarez-Argüelles ME, Purriños MJ.
    Virol J; 2017 Nov 06; 14(1):214. PubMed ID: 29110680
    [Abstract] [Full Text] [Related]

  • 3. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer.
    Guan P, Howell-Jones R, Li N, Bruni L, de Sanjosé S, Franceschi S, Clifford GM.
    Int J Cancer; 2012 Nov 15; 131(10):2349-59. PubMed ID: 22323075
    [Abstract] [Full Text] [Related]

  • 4. Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
    Song F, Yan P, Huang X, Wang C, Du H, Qu X, Wu R.
    BMC Cancer; 2022 Jan 06; 22(1):42. PubMed ID: 34991494
    [Abstract] [Full Text] [Related]

  • 5. Associations of Human Papillomavirus (HPV) genotypes with high-grade cervical neoplasia (CIN2+) in a cohort of women living with HIV in Burkina Faso and South Africa.
    Kelly HA, Ngou J, Chikandiwa A, Sawadogo B, Gilham C, Omar T, Lompo O, Doutre S, Meda N, Weiss HA, Delany-Moretlwe S, Segondy M, Mayaud P, HARP Study Group.
    PLoS One; 2017 Jan 06; 12(3):e0174117. PubMed ID: 28333966
    [Abstract] [Full Text] [Related]

  • 6. Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trial.
    Zhao FH, Zhu FC, Chen W, Li J, Hu YM, Hong Y, Zhang YJ, Pan QJ, Zhu JH, Zhang X, Chen Y, Tang H, Zhang H, Durand C, Datta SK, Struyf F, Bi D, HPV-039 study group.
    Int J Cancer; 2014 Dec 01; 135(11):2604-11. PubMed ID: 24740547
    [Abstract] [Full Text] [Related]

  • 7. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa.
    Denny L, Adewole I, Anorlu R, Dreyer G, Moodley M, Smith T, Snyman L, Wiredu E, Molijn A, Quint W, Ramakrishnan G, Schmidt J.
    Int J Cancer; 2014 Mar 15; 134(6):1389-98. PubMed ID: 23929250
    [Abstract] [Full Text] [Related]

  • 8. Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisation.
    Mesher D, Cuschieri K, Hibbitts S, Jamison J, Sargent A, Pollock KG, Powell N, Wilson R, McCall F, Fiander A, Soldan K.
    J Clin Pathol; 2015 Feb 15; 68(2):135-40. PubMed ID: 25410654
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.
    Xiao M, Xu Q, Li H, Gao H, Bie Y, Zhang Z.
    Medicine (Baltimore); 2016 Jan 15; 95(3):e2555. PubMed ID: 26817906
    [Abstract] [Full Text] [Related]

  • 10. Potential impact of nonavalent HPV vaccine in the prevention of high-grade cervical lesions and cervical cancer in Portugal.
    Pista A, de Oliveira CF, Lopes C, Cunha MJ, CLEOPATRE Portugal study group.
    Int J Gynaecol Obstet; 2017 Oct 15; 139(1):90-94. PubMed ID: 28632949
    [Abstract] [Full Text] [Related]

  • 11. Distribution of high-risk human papillomavirus genotypes among HIV-negative women with and without cervical intraepithelial neoplasia in South Africa.
    McDonald AC, Denny L, Wang C, Tsai WY, Wright TC, Kuhn L.
    PLoS One; 2012 Oct 15; 7(9):e44332. PubMed ID: 22970201
    [Abstract] [Full Text] [Related]

  • 12. Prevalence and type distribution of human papillomavirus in healthy Japanese women aged 20 to 25 years old enrolled in a clinical study.
    Konno R, Tamura S, Dobbelaere K, Yoshikawa H.
    Cancer Sci; 2011 Apr 15; 102(4):877-82. PubMed ID: 21251162
    [Abstract] [Full Text] [Related]

  • 13. Prevalence and distribution of cervical human papillomavirus genotypes in women with cytological results from Sichuan province, China.
    Li B, Wang H, Yang D, Ma J.
    J Med Virol; 2019 Jan 15; 91(1):139-145. PubMed ID: 29981172
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
    Luo HX, Du H, Liu ZH, Zhang LJ, Wang C, Wu RF.
    Zhonghua Zhong Liu Za Zhi; 2018 Mar 23; 40(3):232-238. PubMed ID: 29575846
    [Abstract] [Full Text] [Related]

  • 15. Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance.
    Insinga RP, Perez G, Wheeler CM, Koutsky LA, Garland SM, Leodolter S, Joura EA, Ferris DG, Steben M, Hernandez-Avila M, Brown DR, Elbasha E, Muñoz N, Paavonen J, Haupt RM, FUTURE I Investigators.
    Cancer Epidemiol Biomarkers Prev; 2011 Feb 23; 20(2):287-96. PubMed ID: 21300618
    [Abstract] [Full Text] [Related]

  • 16. Cervical intraepithelial neoplasia grade 2 or worse in Galicia, Spain: HPV 16 prevalence and vaccination impact.
    Pérez-Castro S, Lorenzo-Mahía Y, Iñarrea Fernández A, Lamas-González MJ, Sarán-Díez MT, Rubio-Alarcón J, Reboredo-Reboredo MC, Mosteiro-Lobato S, López-Miragaya I, Torres-Piñón J, Melón-García S.
    Enferm Infecc Microbiol Clin; 2014 Oct 23; 32(8):479-85. PubMed ID: 24274937
    [Abstract] [Full Text] [Related]

  • 17. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of three cohorts from randomized trials.
    Lehtinen M, Lagheden C, Luostarinen T, Eriksson T, Apter D, Harjula K, Kuortti M, Natunen K, Palmroth J, Petäjä T, Pukkala E, Siitari-Mattila M, Struyf F, Nieminen P, Paavonen J, Dubin G, Dillner J.
    BMJ Open; 2017 Aug 18; 7(8):e015867. PubMed ID: 28821519
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis.
    Ogembo RK, Gona PN, Seymour AJ, Park HS, Bain PA, Maranda L, Ogembo JG.
    PLoS One; 2015 Aug 18; 10(4):e0122488. PubMed ID: 25875167
    [Abstract] [Full Text] [Related]

  • 19. Human papillomavirus infection and associated factors for cervical intraepithelial neoplasia in women living with HIV in China: a cross-sectional study.
    Wang Q, Ma X, Zhang X, Ong JJ, Jing J, Zhang L, Wang LH.
    Sex Transm Infect; 2019 Mar 18; 95(2):140-144. PubMed ID: 30337414
    [Abstract] [Full Text] [Related]

  • 20. Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology.
    Stoler MH, Wright TC, Parvu V, Yanson K, Cooper CK, Andrews J.
    Gynecol Oncol; 2019 Apr 18; 153(1):26-33. PubMed ID: 30638767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.